Drug Actives from Bench into Market.
Home About Girindus Capabilities Investor Relations Join us Events Contact us Sitemap
Deutsch
CONTACT.HTML

Your  direct  line

For information on Girindus, please contact:

Ralf Penner
Investor Relations

Tel.: +49 2204 926900
Fax: +49 2204 926990
rpenner@girindus.com

back to top